Wednesday, March 18 10am–12:30pm
Pain Management in Practice: Key Principles for Primary Care Providers
Wednesday, March 18 1:30–2:30pm
Wednesday, March 18 2:45–3:45pm
Breathing Easy: Strategies for Optimizing Obstructive Sleep Apnea Diagnosis and Management
Thursday, March 19 1:15–2:15pm
What Should I Do Next? How to Approach Unexpected Labs in Primary Care
Wednesday, March 18 10am–12:30pm
Pain Management in Practice: Key Principles for Primary Care Providers
Wednesday, March 18 10am–12:30pm
Pain Management in Practice: Key Principles for Primary Care Providers
Thursday, March 19 10:30–11:30am
Cardiology Guidelines to Practice: 2026 Updates in HTN and Lipid Management
Thursday, March 19 2:30–4pm
EKGs Made Practical: Rhythms, Rates, and Red Flags for Primary Care
Thursday, March 19 7:30–8:30am
AI - The Good, The Bad, and The Ugly (Navigating the New Reality of AI in Medicine)
Wednesday, March 18 4:45–6:15pm
Conversations that Count: Building Skills to Motivate Sustainable Weight Change
Thursday, March 19 2:30–4pm
EKGs Made Practical: Rhythms, Rates, and Red Flags for Primary Care
Thursday, March 19 8:30–9:30am
Live Ortho Demonstration: Shoulder and Knee Exams for Primary Care
Wednesday, March 18 7:30–8:15am
Rash Decisions: Recognizing and Managing Common Skin Conditions
Wednesday, March 18 2:45–3:45pm
Breathing Easy: Strategies for Optimizing Obstructive Sleep Apnea Diagnosis and Management
Wednesday, March 18 8:15–9am
Wednesday, March 18 4:45–6:15pm
Conversations that Count: Building Skills to Motivate Sustainable Weight Change
Earn CME/CE credits in Washington, D.C.
Register NowFinancial Disclosures
- Charles E. Argoff, MD, FABPM
- Researcher: AbbVie; Speaker: AbbVie, Averitas Pharma, Eli Lilly, Impel Pharmaceuticals, Kowa Pharmaceuticals, Lundbeck, Nevro Corporation, Scilex Pharmaceuticals, Teva Pharmaceuticals; Consultant: Collegium Pharmaceutical, Nevro Corporation, Pain Scripts, Scilex Pharmaceuticals, Shiratronics, Tris Pharma, Vertamical, Vertex Pharmaceuticals, and Xgene Pharma; Other: Lundbeck and Teva Pharmaceuticals; Stock Holder (publicly traded company): Pfizer and Trevena
- Andrew E. Budson, MD
- Advisor: AbbVie; Speaker: Eli Lilly; Researcher: Vox Neuro, Eisai
- Amy Clouse, MD, FAAFP
- Stock Holder (publicly traded company): Eli Lilly and Novo Nordisk Inc.
- Oscar A. de Leon-Casasola, MD
- No relevant financial relationships disclosed.
- Katherine E. Galluzzi, DO, CMD, FACOFP
- Advisor: Eli Lilly
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Consultant: OptumRx
- Pamela Kushner, MD, FAAFP
- Advisor: GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novo Nordisk, Lilly, Bausch/SALIX, Haleon, Verdiva, Abbott, Corcept, and Bayer; Speaker: GlaxoSmithKline, Boehringer Ingelheim, Phathom, AstraZeneca, Novo Nordisk, Lilly, Janssen, Haleon, Corcept, and Lilly
- Peter Lin, MD, CCFP
- Speaker: Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Sanofi
- Joynita R. Nicholson, DO, DABOM, MFOMA
- Advisor: Corcept Therapeutics
- Vani Potluri, MD, DABOM
- No relevant financial relationships disclosed.
- Jeffrey Rado, MD, MPH, FAPA
- Speaker: Alkermes, Axsome Therapeutics, Bristol Myers Squibb; Independent Contractor: Bristol Myers Squibb, Johnson & Johnson, ALTO Neurosciences, Cerevel, Teva, Neurocrine, Relmada, Neurorelief, Click Therapeutics, NRX Pharmaceuticals
- Arun J. Ramappa, MD
- No relevant financial relationships disclosed.
- Vicky Ren, MD, FAAD
- No relevant financial relationships disclosed., No relevant financial relationships disclosed.
- Athica Vatanapradith, MD, DABOM
- Speaker: Inspire
- Charles Vega, MD, FAAFP
- Consultant: GlaxoSmithKline, Boehringer Ingelheim, Exact Sciences
Other Disclosures
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.